This study aims to identify the effects of exercise type on estrogen, tu-mor markers, immune function, antioxidant function, and physical fit-ness in postmenopausal obese women. The subjects were 30 post-menopausal obese women with body fat percentage higher than 30%. Participants were divided into aerobic exercise group (n=10; age, 53.70±3.37 years), resistance exercise group (n=10; age, 52.20±2.15 years), and control group (n=10; age, 52.50±2.68 years). Estrogen and growth hormone showed no significant difference in the aerobic exer-cise group, resistance exercise group, and control group. Tumor marker alpha-fetoprotein was increased in the aerobic exercise, resistance ex-ercise, and control groups (P < 0.01). The metabolic syndrome risk factor was decreased in the aerobic and resistance exercise groups, which was shown by the reduction of weight (P < 0.001), body fat percentage (P < 0.001), waist circumference (P < 0.05), and increase of high density lipoprotein-cholesterol (P < 0.001). natural killer cell activity was in-creased in the aerobic exercise group, resistance exercise group, and control group (P < 0.001). Oxidative stress was decreased in the aerobic exercise group, resistance exercise group, and control group (P < 0.001). Maximum oxygen uptake was increased in the aerobic and resistance exercise groups, but aerobic exercise was more effective (P < 0.05). Knee isokinetic extensor muscle was increased in both the aerobic and resistance exercise groups (P < 0.001). Aerobic and resistance exercise of postmenopausal obese women can be considered an effective inter-vention program to prevent metabolic syndrome and improve physical fitness.
CITATION STYLE
Yoon, J. R., Ha, G. C., Ko, K. J., & Kang, S. J. (2018). Effects of exercise type on estrogen, tumor markers, immune function, antioxidant function, and physical fitness in postmenopausal obese women. Journal of Exercise Rehabilitation, 14(6), 1032–1040. https://doi.org/10.12965/jer.1836446.223
Mendeley helps you to discover research relevant for your work.